PALASYO SA PUBLIKO: HINTAYIN MUNA ANG REKOMENDASYON NG FDA BAGO GUMAMIT NG IVERMECTIN

Ni Monica N. Ladisla
Source: PTV News
Share on facebook
Facebook
Share on twitter
Twitter
Share on email
Email

Hinikayat ng Palasyo ang publiko na hintayin muna ang desisyon ng Food and Drug Administration (FDA) kaugnay sa paggamit ng anti-parasitic drug na Ivermectin sa mga tao.

Ito ay matapos kumalat na mabisang lunas at panangga umano ang Ivermectin laban sa COVID-19. Ilang doktor na rin ang umapela sa gobyerno na gawin itong available para sa mga pasyenteng hindi na makapasok sa mga ospital.

“Ang ating pakiusap, antayin na lang natin kasi mabilisan naman ‘yang decision ng FDA na ‘yan. Hindi naman magtatagal ‘yan,” pahayag ni Sec. Roque.

Ayon kay Presidential Spokesperson Harry Roque, wala pa umanong sapat na ebidenya na mabisa ang Ivermectin laban sa COVID-19  subalit, mayroon na umanong application na isinumite sa FDA para sa compassionate use nito.

“Ito naman ay para sa ating interes din, dahil kinakailangan mapatunayan na mabisa at epektibo at ligtas ang gamot na ito para sa COVID-19,” ani Sec. Roque.

Samantala, nanindigan pa rin ang Department of Health at FDA sa paggamit ng Ivermectin sa tao sapagkat wala pa umanong sapat na patunay na epektibo nga ito laban sa COVID-19.

Sa kasalukuyan, veterinary grade lamang ng Ivermectin ang commercially available sa bansa.

CONTACT US

Anchored on its mantra, “Sentro ng Katotohanan, Tapat sa Mamamayan”, Balita Central Digital complements and supports the Balita Central newspaper published bi-monthly to combat fake news and to provide the public with easy-to-digest news bits that are sourced solely from the Presidency and government agencies. 

Balita Central is under the supervision of the Bureau of Communications Services (BCS), one of the attached agencies of the Presidential Communications Operations Office (PCOO).

Launched on February 28, 2019 at the Manila Light Rail Transit System Line 2 (LRT-2) Cubao Station, Quezon City, it also aims to raise awareness among local communities about the policies, programs, and accomplishments of the Presidency. 

Through this platform, Balita Central Digital aims to reach further the online community to deliver more accurate information and communication services in order to educate the citizenry regarding national issues which would enlighten them to be engaged and be empowered in contributing to building a better nation.

Balita Central is situated at the BCS Headquarters located beside the Philippine Cancer Society along San Rafael, San Miguel, Malacañang Complex, Manila City. Its official website address is balitacentral.ph.

For inquiries and feedback, Balita Central may be contacted at editorialdesk.bcs@gmail.com.